UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 5 Issue 11
November-2018
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1811A23


Registration ID:
192085

Page Number

161-170

Share This Article


Jetir RMS

Title

Stability Indicating Assay Method Development And Validation Of Dapagliflozin In Pharmaceutical Dosage Form By RP-HPLC

Abstract

A Specific, precise, and accurate RP-HPLC method has been developed and validated for the quantitative analysis of Dapagliflozin in tablet formulation. A Gradient separation was achieved using a X-Select HSS T3 (150mm x 4.6 mm), 3.5µm column with a flow rate of 1.2ml/min and PDA detector at 225nm. Gradient elution was performed with mobile phase-A, Buffer: Methanol (90:10% v/v) and mobile phase-B is Acetonitrile: Milli-Q water (90:10%v/v). The Diluent consists of water and Acetonitrile in the ratio of 20:80%v/v. The method was validated for specificity, linearity, precision, accuracy and robustness. The specificity of the method was determined by assessing interference from the blank, placebo, known impurities and by stress testing the drug product (forced degradation). The method was linear over the concentration range 15-150 ppm (r2 = 1.0). The accuracy of the method was between 98.8-101.4%. The method was found to be Robust and suitable for the quantitative analysis of Dapagliflozin in a tablet formulation. Degradation products resulting from the stress studies did not interfere with the detection of Dapagliflozin peak in chromatogram, demonstrating the stability-indicating method.

Key Words

Stability indicating method, RP-HPLC, Gradient Technique

Cite This Article

"Stability Indicating Assay Method Development And Validation Of Dapagliflozin In Pharmaceutical Dosage Form By RP-HPLC", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 11, page no.161-170, November-2018, Available :http://www.jetir.org/papers/JETIR1811A23.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Stability Indicating Assay Method Development And Validation Of Dapagliflozin In Pharmaceutical Dosage Form By RP-HPLC", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 11, page no. pp161-170, November-2018, Available at : http://www.jetir.org/papers/JETIR1811A23.pdf

Publication Details

Published Paper ID: JETIR1811A23
Registration ID: 192085
Published In: Volume 5 | Issue 11 | Year November-2018
DOI (Digital Object Identifier):
Page No: 161-170
Country: Karimnagar, Telangana, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002940

Print This Page

Current Call For Paper

Jetir RMS